Francisco Partners to invest in Quantros

Quantros, Inc., a leading provider of healthcare software and services for data management, decision support analytics, and clinical business intelligence, today announced that Francisco Partners, one of the world's largest technology-focused private equity firms, has agreed to make a significant capital investment in the company. Quantros' products and services enable and empower healthcare provider improvements in patient safety, quality and compliance. Quantros continues to experience significant growth as a result of the healthcare industry's increasing focus on improving the quality of patient care and medical outcomes. The company's expansive market penetration, industry leadership, suite of software solutions, and the opportunity to further accelerate growth were key drivers for Francisco Partners' investment.

“Quantros remains committed to providing software and services that dramatically improve the clinical, operational and financial performance of healthcare providers”

The company's mission from inception has been to transform a wealth of healthcare data into actionable knowledge that can empower healthcare industry professionals to improve patient safety, quality and compliance. Today, more than 2,000 healthcare facilities throughout the United States use Quantros solutions to improve patient care, increase operational efficiency, reduce costs, ensure compliance, and minimize risk exposure.

"Quantros remains committed to providing software and services that dramatically improve the clinical, operational and financial performance of healthcare providers," said Dr. Sanjaya Kumar, Co-Founder, President and CEO of Quantros, Inc. "Our alliance with Francisco Partners will help accelerate this journey for both Quantros and the many valued clients who rely on our solutions to help provide a safe, high quality care environment. By joining forces with Francisco Partners, we will be able to accelerate key investments in people, processes and technology and to continue building improved solutions and services for our customers."

"The ever increasing emphasis on the quality of patient care and the desire to transform data from across the enterprise into actionable knowledge are driving dramatic changes within the healthcare industry. Quantros has built a reputation as a leader within the quality, safety, and compliance market through its innovative, web-based solutions. We look forward to working with the Quantros management team to continue to drive innovative, reliable solutions that increase efficiency, reduce costs and drive improved outcomes for care providers and their patients" said Ezra Perlman, a partner with Francisco Partners and the head of its healthcare IT practice.

Francisco Partners has considerable experience within the healthcare IT sector. Quantros represents Francisco Partners' seventh investment in the healthcare IT industry, joining its current portfolio of companies - AdvancedMD, API Healthcare, Healthland, QuadraMed, and T-System, as well as a former portfolio company, LYNX Medical Systems, which was acquired by Picis, Inc. in 2007.

B.C. Ziegler and Company acted as financial advisor to Quantros on this transaction.

Source:

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How Fluidics is Powering Modern Healthcare and Medical Device Innovation